131 related articles for article (PubMed ID: 7000179)
1. Divergence of the in vitro biological activity and receptor binding affinity of a synthetic insulin analogue, [21-asparaginamide-A]insulin.
Burke GT; Chanley JD; Okada Y; Cosmatos A; Ferderigos N; Katsoyannis PG
Biochemistry; 1980 Sep; 19(20):4547-56. PubMed ID: 7000179
[TBL] [Abstract][Full Text] [Related]
2. An insulin analogue possessing higher in vitro biological activity than receptor binding affinity. [21-Proline-B]insulin.
Schwartz GP; Burke GT; Chanley JD; Katsoyannis PG
Biochemistry; 1983 Sep; 22(19):4561-7. PubMed ID: 6354263
[TBL] [Abstract][Full Text] [Related]
3. [12-asparagine-B] human insulin. An analogue with modification in the hydrophobic core of insulin.
Schwartz GP; Burke GT; Katsoyannis PG
Int J Pept Protein Res; 1981 Feb; 17(2):243-55. PubMed ID: 7014485
[TBL] [Abstract][Full Text] [Related]
4. Effect of N-methylation of selected peptide bonds on the biological activity of insulin. [2-N-methylisoleucine-A]insulin and [3-N-methylvaline-A]insulin.
Ogawa H; Burke GT; Chanley JD; Katsoyannis PG
Int J Pept Protein Res; 1987 Oct; 30(4):460-73. PubMed ID: 3323092
[TBL] [Abstract][Full Text] [Related]
5. Possible involvement of the A20-A21 peptide bond in the expression of the biological activity of insulin. 3. [21-Desasparagine,20-cysteine ethylamide-A]insulin and [21-desasparagine,20-cysteine 2,2,2-trifluoroethylamide-A]insulin.
Chu YC; Wang RY; Burke GT; Chanley JD; Katsoyannis PG
Biochemistry; 1987 Nov; 26(22):6975-9. PubMed ID: 3322395
[TBL] [Abstract][Full Text] [Related]
6. The A14 position of insulin tolerates considerable structural alterations with modest effects on the biological behavior of the hormone.
Chu YC; Zong L; Burke GT; Katsoyannis PG
J Protein Chem; 1992 Oct; 11(5):571-7. PubMed ID: 1360216
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of an insulin analogue embodying a strongly fluorescent moiety, [19-tryptophan-A]insulin.
Ohta N; Burke GT; Katsoyannis PG
J Protein Chem; 1988 Feb; 7(1):55-65. PubMed ID: 3076448
[TBL] [Abstract][Full Text] [Related]
8. The effect of placement of tryptophan residues in selected A-chain positions on the biological profile of insulin.
Chu YC; Burke GT; Ross JB; Katsoyannis PG
J Protein Chem; 1993 Aug; 12(4):499-505. PubMed ID: 8251071
[TBL] [Abstract][Full Text] [Related]
9. Possible involvement of the A20-A21 peptide bond in the expression of the biological activity of insulin. 1. [21-Desasparagine,20-cysteinamide-A]insulin and [21-desasparagine,20-cysteine isopropylamide-A]insulin.
Chu YC; Wang RY; Burke GT; Chanley JD; Katsoyannis PG
Biochemistry; 1987 Nov; 26(22):6966-71. PubMed ID: 3322393
[TBL] [Abstract][Full Text] [Related]
10. Receptor-isoform-selective insulin analogues give tissue-preferential effects.
Vienberg SG; Bouman SD; Sørensen H; Stidsen CE; Kjeldsen T; Glendorf T; Sørensen AR; Olsen GS; Andersen B; Nishimura E
Biochem J; 2011 Dec; 440(3):301-8. PubMed ID: 21851336
[TBL] [Abstract][Full Text] [Related]
11. [A2-Norleucine]insulin. An analog with unanticipated biological properties.
Okada Y; Chanley JD; Burke GT; Katsoyannis PG
Hoppe Seylers Z Physiol Chem; 1981 Jun; 362(6):629-38. PubMed ID: 7024085
[TBL] [Abstract][Full Text] [Related]
12. Possible involvement of the A20-A21 peptide bond in the expression of the biological activity of insulin. 2. [21-Asparagine diethylamide-A]insulin.
Chu YC; Burke GT; Chanley JD; Katsoyannis PG
Biochemistry; 1987 Nov; 26(22):6972-5. PubMed ID: 3322394
[TBL] [Abstract][Full Text] [Related]
13. A superactive insulin: [B10-aspartic acid]insulin(human).
Schwartz GP; Burke GT; Katsoyannis PG
Proc Natl Acad Sci U S A; 1987 Sep; 84(18):6408-11. PubMed ID: 3306677
[TBL] [Abstract][Full Text] [Related]
14. Interaction between the A2 and A19 amino acid residues is of critical importance for high biological activity in insulin: [19-leucine-A]insulin.
Kitagawa K; Ogawa H; Burke GT; Chanley JD; Katsoyannis PG
Biochemistry; 1984 Sep; 23(19):4444-8. PubMed ID: 6386048
[TBL] [Abstract][Full Text] [Related]
15. Nature of the B10 amino acid residue. Requirements for high biological activity of insulin.
Burke GT; Schwartz G; Katsoyannis PG
Int J Pept Protein Res; 1984 Apr; 23(4):394-401. PubMed ID: 6373642
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo potency of insulin analogues designed for clinical use.
Vølund A; Brange J; Drejer K; Jensen I; Markussen J; Ribel U; Sørensen AR; Schlichtkrull J
Diabet Med; 1991 Nov; 8(9):839-47. PubMed ID: 1663018
[TBL] [Abstract][Full Text] [Related]
17. Receptor binding and biological activity of specifically labeled [125I]- and [127I]monoiodoinsulin isomers in isolated rat adipocytes.
Peavy DE; Abram JD; Frank BH; Duckworth WC
Endocrinology; 1984 May; 114(5):1818-24. PubMed ID: 6370667
[TBL] [Abstract][Full Text] [Related]
18. Insulin analogues with modifications at position B26. Divergence of binding affinity and biological activity.
Záková L; Kazdová L; Hanclová I; Protivínská E; Sanda M; Budesínský M; Jirácek J
Biochemistry; 2008 May; 47(21):5858-68. PubMed ID: 18452310
[TBL] [Abstract][Full Text] [Related]
19. Receptor binding and biological potency of several split forms (conversion intermediates) of human proinsulin. Studies in cultured IM-9 lymphocytes and in vivo and in vitro in rats.
Peavy DE; Brunner MR; Duckworth WC; Hooker CS; Frank BH
J Biol Chem; 1985 Nov; 260(26):13989-94. PubMed ID: 4055768
[TBL] [Abstract][Full Text] [Related]
20. In vitro bioactivity of insulin analogues: lipogenic and anti-lipolytic potency and their interaction with the effect of native insulin.
Ellis MJ; Darby SC; Jones RH; Sönksen PH
Diabetologia; 1978 Nov; 15(5):403-10. PubMed ID: 738550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
